LifeMD, Inc. (NASDAQ: LFMD) reported Q2 EPS of ($0.16), $0.06 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $47.3 million versus the consensus estimate of $49.15 million.

For earnings history and earnings-related data on LifeMD, Inc. (LFMD) click here.